- Home
- PRQR vs ISPR Comparison
PRQR vs ISPR Comparison
Compare PRQR & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRQR | ISPR |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | Netherlands | United States |
| Employees | N/A | 81 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 250.7M | 161.5M |
| IPO Year | 2014 | 2023 |
Fundamental Metrics
Financial Performance| Metric | PRQR | ISPR |
|---|---|---|
| Price | $2.13 | $2.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $8.14 | $7.50 |
| AVG Volume (30 Days) | ★ 579.1K | 44.7K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $18,859,556.00 | ★ $118,506,875.00 |
| Revenue This Year | N/A | $11.60 |
| Revenue Next Year | N/A | $40.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.07 | $1.44 |
| 52 Week High | $3.10 | $6.36 |
Technical Indicators
Market Signals| Indicator | PRQR | ISPR |
|---|---|---|
| Relative Strength Index (RSI) | 45.77 | 66.88 |
| Support Level | $2.15 | $2.37 |
| Resistance Level | $2.49 | $2.67 |
| Average True Range (ATR) | 0.18 | 0.23 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 39.74 | 98.88 |
Price Performance
Historical ComparisonAbout PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.